Cervical Device Contraception-2 (Nanopaz)

Bnai Zion Medical Center10 enrolled

Overview

Measure blood progesterone by using cervical device contraception.

A very small cervical device that releases small amount of progesterone 20 mcgm/day. The target of the research is to measure blood progesterone by using the cervical device. This small device delivers progesterone by nanotechnology method.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Healthy

Interventions

Nanopaz contraception deviceOTHER

levonorgestrel and levonorgestrel device for cervical contraception-nantechnolgy method

Eligibility

Sex: FEMALEMin age: 1 MonthMax age: 2 MonthsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 10 healthy women are candidate for hysterectomy Exclusion Criteria: * Women with neoplastic malignancy disease or thrombophylia

Outcomes

Primary Outcomes

blood progesterone measure in blood

Time frame: one to two months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.